<DOC>
	<DOCNO>NCT02033902</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability Fycompa ( Perampanel ) add-on therapy epilepsy patient age great equal 12 year .</brief_summary>
	<brief_title>A Global , Postmarketing Observational Safety Study Evaluate Safety Tolerability Fycompa ( Perampanel ) Add-on Therapy Epilepsy Patients Aged Greater Than Equal 12 Years</brief_title>
	<detailed_description>This global , observational , cohort study patient epilepsy . Multiple treat physician prescribe perampanel approximately 500 patient , observe approximately 52 week .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Inclusion Criteria 1 . Male female patient age great equal 12 year ( regionally appropriate ) time inform consent 2 . Patients prescribed perampanel adjunctive treatment epilepsy within 7 day Screening Visit 3 . Patients provide informed consent Exclusion Criteria 1 . Participation another study involve administration investigational drug device whilst participate observational study 2 . Prior participation perampanel clinical study 3 . Hypersensitivity perampanel</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Epilepsy</keyword>
</DOC>